Clinical trial Recruiting at 1 site Interventional Ages 18 and up

PROMOTE mobile app to improve physical function and wellbeing in lung cancer survivors

Official title: Randomized Trial of a Digital Health Intervention to Improve Physical Function and Wellness of Lung Cancer Survivors

Run by Massachusetts General Hospital · NCT07227623 · Data updated 2026-11-12

This project tests whether the PROMOTE mobile app can help adults with stage I–III non-small cell lung cancer undergoing curative chemotherapy improve their physical function and overall wellbeing.

More Advanced Lung Cancer trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment250 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Drugs / interventionschemotherapy, immunotherapy
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedFebruary 6, 2026
Main results expectedFebruary 28, 2029
Study endsFebruary 28, 2029
Registry record updatedMarch 19, 2026
Trial IDNCT07227623 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) with stage I–III non-small cell lung cancer who are within six weeks of starting curative-intent treatment that includes chemotherapy, have ECOG performance status 0–2, can use an English-language digital app, and receive primary cancer care at a participating site are ideal candidates.

Probably not a fit

Patients with significant uncontrolled psychiatric or cognitive disorders that preclude participation, those unable to use an English-language digital intervention, or patients not receiving curative-intent chemotherapy are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will randomize adults with stage I–III non-small cell lung cancer who are within six weeks of starting curative-intent chemotherapy (with or without immunotherapy) to use the PROMOTE digital health app or receive enhanced usual care consisting of health education materials. The PROMOTE app delivers behavioral support for physical activity, breathlessness and sleep management, and healthy eating, and collects patient-reported outcomes over the treatment period. The primary outcome is patient-reported physical function, with secondary outcomes including dyspnea, sleep disturbance, physical activity, eating behaviors, self-efficacy, mood symptoms, and quality of life. Investigators will also explore mediators and moderators to understand who benefits most from the intervention.

Why it matters

Potential benefit: If effective, PROMOTE could help lung cancer survivors increase activity, reduce breathlessness and sleep problems, and improve quality of life during and after curative treatment.

How similar studies have gone: Behavioral and digital health interventions have shown benefits for physical activity and symptom management in cancer and pulmonary populations, but applying a dedicated app to early-stage lung cancer survivorship care is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* Diagnosis of stage I-III non-small cell lung cancer
* Within six weeks of initiating treatment with curative intent that includes chemotherapy ± immunotherapy in the neo-adjuvant or adjuvant setting with surgery or as part of definitive chemoradiation
* Eastern Cooperative Oncology Group Performance Status = 0-2 (i.e., fully active to at least ambulatory and up and about more than 50% of waking hours)
* Ability to use a digital health intervention that includes verbal and written information in English
* Ability to complete questionnaires in English or Spanish
* Primary cancer care at one of the participating institutions

Exclusion Criteria:

* Significant uncontrolled psychiatric disorder or other co-morbid disease (e.g., dementia, cognitive impairment), which the treating oncology clinician reports would prohibit the patient's ability to participate in study procedures

Where it's running

  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.